What is the recommended dosage of Senna (generic name: Sennosides) for a typical adult patient with constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Senna Dosage for Adult Constipation

Start with 8.6-17.2 mg (1-2 tablets) of senna taken once daily at bedtime, and titrate upward based on response and tolerability. 1, 2

Initial Dosing Strategy

  • Begin with 8.6-17.2 mg daily (equivalent to 1-2 standard tablets) taken at bedtime to allow the 6-12 hour onset of action to produce a morning bowel movement 1, 2
  • For liquid formulations, the FDA-approved dosing is 2-3 teaspoons (10-15 mL) once daily for adults, with a maximum of 3 teaspoons (15 mL) twice daily 3
  • The lower starting dose is critical because clinical trials using 1 gram daily found that 83% of participants had to reduce their dose due to side effects, indicating this higher dose is poorly tolerated 1

Dose Titration and Adjustment

  • Titrate upward only after several days if inadequate response, as the American Gastroenterological Association emphasizes starting low and increasing gradually 1, 2
  • The maximum recommended dose is generally 4 tablets twice per day, though no clear maximum has been established in guidelines 1
  • In palliative care settings for patients with severe constipation and limited life expectancy, higher doses of 2-3 tablets 2-3 times daily may be appropriate, targeting one non-forced bowel movement every 1-2 days 1, 2

Efficacy Evidence

  • Senna significantly increases complete spontaneous bowel movements by 7.60 per week compared to placebo (95% CI 5.90-9.30), with moderate strength of evidence 1
  • Response rates are substantially higher with senna versus placebo (RR 5.25,95% CI 2.05-13.47) 1
  • Both senna and magnesium oxide showed 69% response rates for overall symptom improvement compared to 12% with placebo in a randomized controlled trial 4

Critical Safety Considerations and Monitoring

  • Common side effects include abdominal cramping, diarrhea, and abdominal pain, particularly at higher doses 1, 2
  • Severe diarrhea can lead to significant fluid and electrolyte depletion, particularly potassium, which can cause life-threatening cardiac arrhythmias 1
  • Monitor for hypokalemia in patients on QT-prolonging medications, those with cardiac conditions, or patients taking other medications affecting potassium levels 1
  • Contraindicated in ileus, intestinal obstruction, severe dehydration, or acute inflammatory bowel conditions 1, 2

Important Clinical Pitfalls

  • Not recommended during pregnancy due to potential weak genotoxic effects observed in animal studies 1
  • Antibiotics may decrease senna's efficacy by affecting colonic bacteria that metabolize sennosides to active compounds 1
  • Senna is present in many laxative teas where precise dosing is difficult to calculate 1
  • May be too strong for overtly weak or debilitated patients 2

Duration of Treatment

  • While clinical trials evaluated 4-week treatment periods, longer-term use is appropriate for chronic constipation management, though data on extended use tolerance are limited 1, 2
  • The American Gastroenterological Association conditionally recommends senna over no treatment for chronic idiopathic constipation (low certainty of evidence) 1, 2

When to Escalate Therapy

  • If senna fails at optimal dosing, escalate to prescription secretagogues such as linaclotide, plecanatide, lubiprostone, or prucalopride 5
  • Before escalating, rule out mechanical obstruction or impaction, discontinue non-essential constipating medications, and treat reversible causes (hypercalcemia, hypokalemia, hypothyroidism, diabetes) 5

References

Guideline

Senna Treatment for Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Senna Dosage and Administration for Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Next-Line Therapy for Refractory Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.